CAS RN: 2083627-02-3
EED226
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
99% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250129
5mg / 25mg / 100mg
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2083627-02-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Beijing
Inquiry
2083627-02-3 / N-(furan-2-ylmethyl)-8-(4-methylsulfonylphenyl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-amine
Standard CAS: 2083627-02-3
Multi CAS: No
Basic Information
copy
CAS
2083627-02-3 copy
Multi CAS
No copy
Molecular Formula
C17H15N5O3S copy
Molecular Weight
369.400000 copy
Exact Mass
369.089561 copy
SMILES
CS(=O)(=O)C1=CC=C(C=C1)C2=CN=C(N3C2=NN=C3)NCC4=CC=CO4 copy
InChI
InChI=1S/C17H15N5O3S/c1-26(23,24)14-6-4-12(5-7-14)15-10-19-17(22-11-20-21-16(15)22)18-9-13-3-2-8-25-13/h2-8,10-11H,9H2,1H3,(H,18,19) copy
InChIKey
DYIRSNMPIZZNBK-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
26 copy
Aromatic heavy atom count
20 copy
Fraction Csp3
0.12 copy
Rotatable bonds
5 copy
H-bond acceptors
8 copy
H-bond donors
1 copy
Molar refractivity
95.36 copy
TPSA
102.39 copy
LogP / Solubility
WLOGP
2.4 copy
MLOGP
2.13 copy
XLogP3
2.3 copy
Consensus LogP
2.28 copy
Log S (ESOL)
-3.88 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-4.32 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-4.65 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.27 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
3 copy